Liver Function Tests Interpretation: LFTs in Clinical Medicine

Added:

Limitations of Static 'Liver Function' Tests and the Shift Toward Dynamic and Non-Invasive Biomarkers

A significant critique within hepatology highlights that traditional 'Liver Function Tests' (LFTs) are misnamed; standard panels (like AST, ALT, and ALP) measure hepatocyte injury and biliary patency rather than actual metabolic or synthetic liver function. Critics argue that relying solely on static enzyme patterns (hepatocellular vs. cholestatic) can be misleading due to frequent overlap, transient non-specific fluctuations, and extrahepatic sources (such as bone or muscle). This often leads to unnecessary, costly diagnostic cascades and patient anxiety. Opposing paradigms advocate for a shift toward true quantitative, dynamic liver function assessments (such as Indocyanine Green clearance or breath tests) and validated non-invasive fibrosis biomarkers (like transient elastography/FibroScan and serum panels like ELF). These modern alternatives provide a more accurate representation of actual functional reserve and disease progression, challenging the traditional diagnostic reliance on standard enzyme panels.

Basic anatomy and physiology of the liver, biliary tree, and portal venous system.
Understanding of cellular biochemistry, specifically the role and cellular location of key enzymes (AST, ALT, ALP, GGT) and proteins (albumin).
The metabolic pathway of bilirubin, including the clinical distinction between conjugated and unconjugated hyperbilirubinemia.
General mechanisms of cellular injury, such as hepatocellular necrosis versus cholestasis (bile flow obstruction).
Applying diagnostic workup algorithms for abnormal LFTs, including viral serologies, autoimmune markers, and iron studies.
Using advanced imaging modalities (such as RUQ ultrasound, CT, MRCP, and ERCP) to investigate cholestatic and infiltrative patterns.
Clinical management of specific liver pathologies like Drug-Induced Liver Injury (DILI), Non-Alcoholic Fatty Liver Disease (NAFLD), and Autoimmune Hepatitis.
Calculating and interpreting prognostic liver scores such as the Child-Pugh classification and the Model for End-Stage Liver Disease (MELD) score.
133 views6likes24:20@amplemedicallecturesOriginal Release: 2024-08-02

Abnormal liver function tests (LFTs) do not always indicate liver disease, as physiological conditions like pregnancy and adolescence can cause elevated alkaline phosphatase; the interpretation requires a systematic approach including detailed history, examination, and appropriate investigations to identify the underlying cause, which may include viral hepatitis, alcohol, drug-induced injury, biliary obstruction, or non-hepatic conditions.